Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Lucio Carrozza"'
Autor:
Giacomo Emanuele Maria Rizzo, MD, Mario Traina, MD, Lucio Carrozza, MD, Dario Ligresti, MD, Alessandro Bertani, MD, PhD, Giorgia Tancredi, MD, Chiara Vitiello, MD, Ilaria Tarantino, MD
Publikováno v:
VideoGIE, Vol 8, Iss 12, Pp 479-482 (2023)
Externí odkaz:
https://doaj.org/article/4a9c2ac619cf45f4a95825295676ae55
Autor:
Gabriele Rancatore, Dario Ligresti, Giacomo Emanuele Maria Rizzo, Lucio Carrozza, Mario Traina, Ilaria Tarantino
Publikováno v:
Diagnostics, Vol 14, Iss 13, p 1336 (2024)
Despite the introduction of serological neoplastic biomarkers and typical radiological characteristics in clinical practice, liver biopsy (LB) is often still necessary to establish a histological diagnosis, especially in ambiguous cases. Nowadays, LB
Externí odkaz:
https://doaj.org/article/336ac05199064e45aaeb334b03815341
Autor:
Giacomo Emanuele Maria Rizzo, Silvia Ferriolo, Lucio Carrozza, Gabriele Rancatore, Mario Traina
Publikováno v:
Diagnostics, Vol 14, Iss 11, p 1072 (2024)
These images involved the case of a 51-year-old woman who had a history of chronic abdominal pain, iron deficiency, and diarrhoea but no blood or mucus in her stool. She had never undergone major abdominal surgery, and her past medical evaluation dia
Externí odkaz:
https://doaj.org/article/ebbc963701f248328d8fbf863bf866bd
Autor:
Giacomo Emanuele Maria Rizzo, MD, Lucio Carrozza, MD, Salvatore Tammaro, MD, Dario Ligresti, MD, Mario Traina, MD, Ilaria Tarantino, MD
Publikováno v:
VideoGIE, Vol 8, Iss 8, Pp 310-312 (2023)
Externí odkaz:
https://doaj.org/article/0e687aa95a054f84bbbe55b1218d9e51
Autor:
Emanuele Sinagra, Anita Busacca, Laura Guida, Lucio Carrozza, Daniele Brinch, Federica Crispino, Marcello Maida, Salvatore Battaglia, Ciro Celsa, Calogero Cammà, Maria Cappello
Publikováno v:
Gastroenterology Insights, Vol 13, Iss 1, Pp 117-126 (2022)
Background: The COVID-19 outbreak has led IBD clinics to adopt a remote monitoring approach in order to guarantee an adequate follow-up of patients with inflammatory bowel disease (IBD) and ensure the rules of social distancing. Aim: The aim of the s
Externí odkaz:
https://doaj.org/article/493f3e7aae984486b79719a900cbdd42
Autor:
Laura Guida, Francesca Maria Di Giorgio, Anita Busacca, Lucio Carrozza, Stefania Ciminnisi, Piero Luigi Almasio, Vito Di Marco, Maria Cappello
Publikováno v:
Nutrients, Vol 13, Iss 3, p 759 (2021)
Background: Diet has a relevant role in triggering symptoms in inflammatory bowel disease (IBD) from the patients’ perspective, but there is gap the between patients’ and doctors’ perceptions. Few studies have addressed this topic. The aim of t
Externí odkaz:
https://doaj.org/article/ee272b51d76b4f298902edca84a0b8fb
Autor:
Fabio Salvatore Macaluso, Alessandra Giuliano, Walter Fries, Anna Viola, Alfredo Abbruzzese, Maria Cappello, Enrica Giuffrida, Lucio Carrozza, Antonino Carlo Privitera, Antonio Magnano, Concetta Ferracane, Giuseppe Scalisi, Maria Giovanna Minissale, Emiliano Giangreco, Serena Garufi, Carmelo Bertolami, Ugo Cucinotta, Francesco Graziano, Angelo Casà, Sara Renna, Giulia Teresi, Giulia Rizzuto, Mariella Mannino, Marcello Maida, Ambrogio Orlando
Publikováno v:
Inflammatory Bowel Diseases. 29:217-221
Background Data from the first wave of the coronavirus disease 2019 (COVID-19) pandemic suggested that patients with inflammatory bowel disease (IBD) are not at higher risk of being infected by severe acute respiratory syndrome coronavirus 2 (SARS-Co
Autor:
Giacomo Emanuele Maria Rizzo, Lucio Carrozza, Dario Quintini, Dario Ligresti, Mario Traina, Ilaria Tarantino
Publikováno v:
Cancers. 15:2585
Background: The treatments for cancer palliation in patients with concomitant malignant biliary obstruction (MBO) and gastric outlet obstruction (MGOO) are still under investigation due to the lack of evidence available in the medical literature. We
Autor:
Bezzio, C., Armuzzi, A., Furfaro, F., Ardizzone, S., Milla, M., Carparelli, S., Orlando, A., Caprioli, F. A., Castiglione, F., Vigano, C., Ribaldone, D. G., Zingone, F., Monterubbianesi, R., Imperatore, N., Festa, S., Daperno, M., Scucchi, L., Ferronato, A., Pastorelli, L., Balestrieri, P., Ricci, C., Cappello, M., Felice, C., Fiorino, G., Saibeni, S., Coppini, F., Alvisi, P., Gerardi, V., Variola, A., Mazzuoli, S., Lenti, M. V., Pugliese, D., Allocca, M., Ferretti, F., Roselli, J., Bossa, F., Giuliano, A., Piazza, N., Manes, G., Sartini, A., Buda, A., Micheli, F., Ciardo, V., Casella, G., Viscido, A., Bodini, G., Casini, V., Soriano, A., Amato, A., Grossi, L., Onali, S., Rottoli, M., Spagnuolo, R., Baroni, S., Cortelezzi, C. C., Baldoni, M., Vernero, M., Scaldaferri, F., Maconi, G., Guarino, A. D., Palermo, A., D'Inca, R., Scribano, M. L., Biancone, L., Carrozza, L., Ascolani, M., Costa, F., Di Sabatino, A., Zammarchi, I., Gottin, M., Conforti, F. S.
Publikováno v:
Alimentary Pharmacology & Therapeutics
Summary Background Older age and comorbidities are the main risk factors for adverse COVID‐19 outcomes in patients with inflammatory bowel disease (IBD). The impact of IBD medications is still under investigation. Aims To assess risk factors for ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e9583b014c44969ace8f5c5288d3529
http://hdl.handle.net/11379/556637
http://hdl.handle.net/11379/556637